Ireland· IE-PA-PA23055/015/001
Geodon 20mg capsules, hard
A ziprasidone product containing ziprasidone hydrochloride monohydrate, registered in Ireland by Upjohn EESV. The same ATC class is registered in 14 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Ziprasidone is registered in 14 of 19 countries.
Countries holding a registration under ATC N05AE04 (ziprasidone), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Ziprasidone · ATC N05AE04
14 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ziprasidone costs, country by country.
Normalised to the WHO defined daily dose (80 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ziprasidone · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- US United States$0.54 (acquisition cost)
The record
At a glance
HPRA (Ireland)- Active substance
- Ziprasidone hydrochloride monohydrate
- Manufacturer
- Upjohn EESV
- Country
- Ireland (IE)
- ATC code
- N05AE04
- ATC class
- Ziprasidone
- Defined daily dose
- 80 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- June 15, 2026
Packs & prices · 1
- ie_pa_numberPA23055/015/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
403 interactions on record for ziprasidone.
Graded by severity as the source publishes them — 147 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ziprasidone · interactions on record
403 records
- 147 severe
- 162 moderate
- 38 minor
- 56 info
Most severe, free to view
- PapaverineA03AD01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ziprasidone in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesGeodonViatris Specialty LLC
- SwedenZeldox 20 mg Kapsel, hårdViatris Healthcare Limited
- SpainZELDOX 20 mg CAPSULAS DURASViatris Healthcare Limited
- FinlandZeldoxViatris Healthcare Limited
- IcelandZeldoxViatris ApS
- CanadaAURO-ZIPRASIDONEAURO PHARMA INC
- NorwayZiprasidon ActavisActavis Group PTC ehf
- PolandZypsilaKrka, d.d., Novo mesto
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Zeldox, Ziprasidon Krka
- Bulgaria · Зелдокс, Зипсила
- Cyprus · Geodon
- Czechia · Zeldox, Zypsilan
- Germany · Zeldox, Ziprasidon 1 A Pharma
- Denmark · Zeldox, Ziprasidon Krka
- Spain · Zeldox, Ziprasidona Aurovitas
- Finland · Zeldox, Ziprasidon Krka
- Greece · Geodon, Ziprasidone Actavis
- Croatia · Zeldox
- Hungary · Ypsila, Zeldox
- Iceland · Zeldox, Ziprasidon Actavis
- Italy · Zeldox, Ziprasidone Sandoz
- Lithuania · Zeldox, Zypsilan
- Latvia · Ypsila, Zeldox
- Malta · Ziprasidone Aurobindo
- Norway · Zeldox, Ziprasidon Actavis
- Poland · Zypsila
- Portugal · Zeldox, Ziprasidona Aurobindo
- Romania · Zypsila
- Sweden · Zeldox, Ziprasidon Actavis
- Slovenia · Zeldox, Zypsila
- Slovakia · Zeldox, Zipwell
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4a38ffa8-5c69-4582-9222-25e3e96c538f GET /v1/drugs/4a38ffa8-5c69-4582-9222-25e3e96c538f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N05AE",
"N05AE04"
],
"strength": null,
"pa_number": "PA23055/015/001",
"substances": [
"Ziprasidone hydrochloride monohydrate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "08/03/2002",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about ziprasidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.